Budget impact of preoperative and intermittent ulipristal acetate (UPA) in the exploratory scenario
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
| Cost of UPA | |||||||
| Number of reimbursed treatment units | 5 328 | 34 956 | 54 076 | 78 762 | 86 783 | 107 616 | 130 978 |
| Amount reimbursed by the French national healthcare insurance system (M€) | 0.5 | 3.2 | 5.0 | 7.3 | 8.0 | 9.9 | 12.1 |
| Surgical procedures avoided by the use of UPA | |||||||
| Number of surgical procedures avoided | 724 | 1 942 | 2 979 | 4 472 | 6 539 | 8 380 | 9 509 |
| Costs avoided (M€) | 1.7 | 4.7 | 7.2 | 10.8 | 15.8 | 20.2 | 23.0 |
| Budget impact of UPA | |||||||
| Annual (M€) | −1.3 | −1.5 | −2.2 | −3.5 | −7.8 | −10.3 | −10.9 |
| Cumulative (M€) | −1.3 | −2.7 | −5.0 | −8.5 | −16.3 | −26.6 | −37.4 |